Theramyt Novobiologics investing $10M by 2015 to develop IP platform

By Lohit Jagwani

  • 06 Nov 2013
Premium

Bangalore-based Theramyt Novobiologics Pvt Ltd, which recently raised its first round of funding from various investors including Aarin Capital and Accel Partners, is on its way to develop a platform which couples drug design with development of unique product lines in oncology, rheumatoid arthritis and cardiovascular diseases, among others.“Theramyt’s focus ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.